Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
PUT
Enovis
ENOV
$1.74B
| $108K | ﹤0.01% |
1,511
+58
| +4% | +$4.04K |
|
4802
Ligand Pharmaceuticals
LGND
$6.06B
| $108K | ﹤0.01% |
1,263
-6,314
| -83% | -$500K |
|
|
TRTX
4803
TPG RE Finance Trust
TRTX
$610M
| $108K | ﹤0.01% |
+5,451
| New | +$108K |
|
|
RRD
4804
DELISTED
RR Donnelley & Sons Co.
RRD
| $108K | ﹤0.01% |
10,443
-21,522
| -67% | -$223K |
|
|
OAK
4805
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $108K | ﹤0.01% |
+2,292
| New | +$107K |
|
4806
Erie Indemnity
ERIE
$13.1B
| $107K | ﹤0.01% |
887
+418
| +89% | +$51K |
|
4807
iShares US Aerospace & Defense ETF
ITA
$14.8B
| $107K | ﹤0.01% |
1,194
+222
| +23% | +$18.6K |
|
|
KNDI
4808
PUT
Kandi Technologies Group
KNDI
$69.8M
| $107K | ﹤0.01% |
18,600
+1,300
| +8% | +$5.51K |
|
|
CBAY
4809
DELISTED
Cymabay Therapeutics
CBAY
| $107K | ﹤0.01% |
13,250
-1,509
| -10% | -$10.2K |
|
|
PDLI
4810
DELISTED
PDL BioPharma, Inc.
PDLI
| $107K | ﹤0.01% |
31,499
+16,831
| +115% | +$46.8K |
|
4811
Federal Agricultural Mortgage
AGM
$2.58B
| $106K | ﹤0.01% |
1,458
-5,411
| -79% | -$365K |
|
4812
CALL
Donaldson
DCI
$11.3B
| $106K | ﹤0.01% |
2,300
+2,200
| +2,200% | +$102K |
|
4813
PUT
Federal Signal
FSS
$7.95B
| $106K | ﹤0.01% |
+5,000
| New | +$93.5K |
|
4814
Helix Energy Solutions
HLX
$1.37B
| $106K | ﹤0.01% |
14,234
-50,789
| -78% | -$321K |
|
4815
Kodak
KODK
$965M
| $106K | ﹤0.01% |
14,505
+13,792
| +1,934% | +$115K |
|
4816
CALL
Silicon Motion
SIMO
$8.36B
| $106K | ﹤0.01% |
2,200
-10,200
| -82% | -$452K |
|
4817
PUT
Vicor
VICR
$10.1B
| $106K | ﹤0.01% |
+4,500
| New | +$84.9K |
|
|
XONE
4818
CALL
DELISTED
The ExOne Company
XONE
| $106K | ﹤0.01% |
9,300
+1,600
| +21% | +$15.8K |
|
4819
Costamare
CMRE
$1.77B
| $105K | ﹤0.01% |
16,899
+12,573
| +291% | +$81.3K |
|
4820
PUT
CenterPoint Energy
CNP
$26.8B
| $105K | ﹤0.01% |
3,600
-600
| -14% | -$17.3K |
|
4821
Forte Biosciences
FBRX
$1.57B
| $105K | ﹤0.01% |
+22
| New | +$98K |
|
4822
Olin
OLN
$2.13B
| $105K | ﹤0.01% |
3,078
-235,041
| -99% | -$7.33M |
|
|
WCC
4823
CALL
WESCO International
WCC
$18.2B
| $105K | ﹤0.01% |
1,800
-13,300
| -88% | -$715K |
|
|
VRTU
4824
DELISTED
Virtusa Corporation
VRTU
| $105K | ﹤0.01% |
2,772
-2,670
| -49% | -$91.8K |
|
|
ALX
4825
Alexander's
ALX
$1.42B
| $104K | ﹤0.01% |
245
+144
| +143% | +$60.8K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.